Jill D. Martin

Array ( [id] => 4064235 [patent_doc_number] => 05866551 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-02 [patent_title] => 'Recombinant adero viruses comprising an inserted gene encoding apolipoprotein and their use in gene therapy for dyslipoproteinemias' [patent_app_type] => 1 [patent_app_number] => 8/535243 [patent_app_country] => US [patent_app_date] => 1996-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 12 [patent_no_of_words] => 9124 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/866/05866551.pdf [firstpage_image] =>[orig_patent_app_number] => 535243 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4146126 [patent_doc_number] => 06031149 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-29 [patent_title] => 'Genetically engineered mice containing alterations in the genes encoding retinoic acid receptor proteins' [patent_app_type] => 1 [patent_app_number] => 8/580713 [patent_app_country] => US [patent_app_date] => 1995-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 180 [patent_no_of_words] => 48161 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/031/06031149.pdf [firstpage_image] =>[orig_patent_app_number] => 580713 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4185144 [patent_doc_number] => 06159947 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-12-12 [patent_title] => 'Anti-RAS intracellular binding proteins and use thereof' [patent_app_type] => 1 [patent_app_number] => 8/564164 [patent_app_country] => US [patent_app_date] => 1995-12-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 10688 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/159/06159947.pdf [firstpage_image] =>[orig_patent_app_number] => 564164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3871904 [patent_doc_number] => 05837875 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Transgenic mouse containing an IGF-1 transgene' [patent_app_type] => 1 [patent_app_number] => 8/578245 [patent_app_country] => US [patent_app_date] => 1995-12-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 6138 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 119 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837875.pdf [firstpage_image] =>[orig_patent_app_number] => 578245 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4072627 [patent_doc_number] => 05965440 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-10-12 [patent_title] => 'Controlled gene product delivery from a regulatable retroviral vector' [patent_app_type] => 1 [patent_app_number] => 8/568495 [patent_app_country] => US [patent_app_date] => 1995-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 8 [patent_no_of_words] => 16214 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/965/05965440.pdf [firstpage_image] =>[orig_patent_app_number] => 568495 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4020686 [patent_doc_number] => 05907080 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-05-25 [patent_title] => 'Method for development of transgenic dwarf goats' [patent_app_type] => 1 [patent_app_number] => 8/565057 [patent_app_country] => US [patent_app_date] => 1995-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7400 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 123 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/907/05907080.pdf [firstpage_image] =>[orig_patent_app_number] => 565057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3842495 [patent_doc_number] => 05847257 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-12-08 [patent_title] => 'Transgenic mouse deficient in T-cells' [patent_app_type] => 1 [patent_app_number] => 8/558651 [patent_app_country] => US [patent_app_date] => 1995-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 2987 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 84 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/847/05847257.pdf [firstpage_image] =>[orig_patent_app_number] => 558651 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3876939 [patent_doc_number] => 05824840 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-10-20 [patent_title] => 'Diabetes-inducing transgenic mouse' [patent_app_type] => 1 [patent_app_number] => 8/558719 [patent_app_country] => US [patent_app_date] => 1995-11-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 6 [patent_no_of_words] => 3237 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 93 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/824/05824840.pdf [firstpage_image] =>[orig_patent_app_number] => 558719 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4000703 [patent_doc_number] => 05986171 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-16 [patent_title] => 'Method for examining neurovirulence of polio virus' [patent_app_type] => 1 [patent_app_number] => 8/549701 [patent_app_country] => US [patent_app_date] => 1995-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 7 [patent_no_of_words] => 5313 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 124 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/986/05986171.pdf [firstpage_image] =>[orig_patent_app_number] => 549701 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3889807 [patent_doc_number] => 05714667 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-02-03 [patent_title] => 'Mice lacking expression of CTLA-4 receptor' [patent_app_type] => 1 [patent_app_number] => 8/554133 [patent_app_country] => US [patent_app_date] => 1995-11-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 9383 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/714/05714667.pdf [firstpage_image] =>[orig_patent_app_number] => 554133 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4105965 [patent_doc_number] => 06022737 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-02-08 [patent_title] => 'Formulations for non-viral in vivo transfection in the lungs' [patent_app_type] => 1 [patent_app_number] => 8/556780 [patent_app_country] => US [patent_app_date] => 1995-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 8 [patent_no_of_words] => 6015 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/022/06022737.pdf [firstpage_image] =>[orig_patent_app_number] => 556780 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4134583 [patent_doc_number] => 06060052 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-05-09 [patent_title] => 'Methods for use of Mpl ligands with primitive human hematopoietic stem cells' [patent_app_type] => 1 [patent_app_number] => 8/550167 [patent_app_country] => US [patent_app_date] => 1995-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 19 [patent_no_of_words] => 15058 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 80 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/060/06060052.pdf [firstpage_image] =>[orig_patent_app_number] => 550167 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4133431 [patent_doc_number] => 06121246 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'Method for treating ischemic tissue' [patent_app_type] => 1 [patent_app_number] => 8/545998 [patent_app_country] => US [patent_app_date] => 1995-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 7085 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 176 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121246.pdf [firstpage_image] =>[orig_patent_app_number] => 545998 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3739242 [patent_doc_number] => 05698767 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-16 [patent_title] => 'Human immune system in non-human animal' [patent_app_type] => 1 [patent_app_number] => 8/543449 [patent_app_country] => US [patent_app_date] => 1995-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 9502 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/698/05698767.pdf [firstpage_image] =>[orig_patent_app_number] => 543449 [rel_patent_id] =>[rel_patent_doc_number] =>)